This Week in MMWR - Vol. 71, January 21, 2022

["Morbidity and Mortality Weekly Report \(MMWR\) \(CDC\)" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

Reports on Zoster Vaccines, Zika-Associated Birth Defects, and more

January 21, 2022 

Check out the latest COVID-19 reports here.

SURVEILLANCE SUMMARIES

Disease Surveillance Among U.S.-Bound Immigrants and Refugees — Electronic Disease Notification System, United States, 2014–2019 This report summarizes tuberculosis and other health-related information reported to CDC for refugees, immigrants, and eligible others who arrived in the United States during 2014–2019.

WEEKLY REPORT

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 On October 20, 2021, the Advisory Committee on Immunization Practices recommended 2 recombinant zoster vaccine doses for prevention of herpes zoster and related complications in immunodeficient or immunosuppressed adults aged ≥19 years.

• Zika-Associated Birth Defects Reported in Pregnancies with Laboratory Evidence of Confirmed or Possible Zika Virus Infection — U.S. Zika Pregnancy and Infant Registry, December 1, 2015–March 31, 2018
• Progress Toward Poliomyelitis Eradication — Afghanistan, January 2020–November 2021
• Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
• Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021
• Notes from the Field: Early Evidence of the SARS-CoV-2 B.1.1.529 (Omicron) Variant in Community Wastewater — United States, November–December 2021

READ MORE

QUICKSTATS

Percentage of Children Aged 2–17 Years With >2 Hours of Screen Time Per Weekday, by Sex and Age Group — National Health Interview Survey, United States, 2020

PDF of Surveillance Summaries (link) and the Weekly Issue (link).

CONTINUING EDUCATION

READ MORE

MMWR Weekly COVID-19 Briefing Podcast: Week of January 3

The latest MMWR Weekly COVID-19 Briefing is live. This episode covers four reports, including reports highlighting the effectiveness of the Pfizer-BioNTech vaccine against MIS-C in children, the risk for diabetes in children after COVID-19 infection and more. Listen & subscribe: Apple Podcasts, Stitcher, Spotify, and Google Play.